Zepp Health Corporation(ZEPP)Earnings, Financials & Key Ratios
ZEPP•NYSE
Price updated Jun 19, 2026
AboutZepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.Show more
- Revenue$1.82B+36.1%
- EBITDA-$205M+33.6%
- Net Income-$281M+49.3%
- EPS (Diluted)-283.04-728.6%
- Gross Margin39.2%+1.9%
- EBITDA Margin-11.29%+51.2%
- Operating Margin-11.29%+56.4%
- Net Margin-15.48%+62.8%
- ROE-16.8%+34.2%
ZEPP Key Insights
Zepp Health Corporation (ZEPP) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Share count reduced 93.9% through buybacks
- ✓Trading at only 0.0x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 2 (bottom 2%)
- ✗Sales declining 21.5% over 5 years
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ZEPP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ZEPP Price & Volume
Zepp Health Corporation (ZEPP) stock price & volume — 10-year historical chart
Loading chart...
ZEPP Growth Metrics
Zepp Health Corporation (ZEPP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.97%
5 Years-21.48%
3 Years-24.49%
TTM40.29%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM47.42%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-218.98%
Return on Capital
10 Years7.06%
5 Years-7.19%
3 Years-9.13%
Last Year-9.37%
ZEPP Recent Earnings
Zepp Health Corporation (ZEPP) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 0/12 qtrs (0%)●Beat Revenue 0/12 qtrs (0%)
Q3 2026Latest
Jun 9, 2026Metric
Actual
Est
EPS
$1.13
—
Rev
$39M
—
Q2 2026
Mar 16, 2026Metric
Actual
Est
EPS
$0.40
—
Rev
$85M
—
Q2 2026
Mar 15, 2026Metric
Actual
Est
EPS
$0.40
—
Rev
$85M
—
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.04
—
Rev
$76M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 9, 2026 | $1.13 | $39M |
| Q2 2026 | Mar 16, 2026 | $0.40 | $85M |
| Q2 2026 | Mar 15, 2026 | $0.40 | $85M |
| Q4 2025 | Nov 4, 2025 | $0.04 | $76M |
Based on last 12 quarters of dataView full earnings history →
ZEPP Peer Comparison
Zepp Health Corporation (ZEPP) competitors in Wearables and emerging AR devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 GRMN | 45.17B | 234.20 | 27.26 | 15.06% | 23.26% | 19.93% | 0.02 | |
 FOSL | 253.55M | 4.29 | -2.96 | -12.28% | -6.18% | -61.58% | 3.25 | |
 SMPL | 1.26B | 12.63 | 12.38 | 8.98% | 6.26% | 5.23% | 0.17 | |
 AAPL | 4.38T | 298.01 | 39.95 | 6.43% | 27.15% | 146.69% | 1.52 | |
 FITB | 35.29B | 52.74 | 14.90 | -1.4% | 19.61% | 11.96% | 0.67 | |
 GOOGL | 4.45T | 368.03 | 34.05 | 15.13% | 37.91% | 38.98% | 0.14 | |
 QCOM | 238.32B | 226.11 | 45.13 | 13.66% | 22.31% | 40.19% | 0.77 | |
 SWKS | 10.9B | 72.45 | 23.52 | -2.18% | 8.93% | 6.3% | 0.21 |
Compare ZEPP vs Peers
Zepp Health Corporation (ZEPP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ZEPP Income Statement
Zepp Health Corporation (ZEPP) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2B | 3.79B | 5.8B | 6.08B | 6.17B | 4.22B | 2.5B | 1.33B | 1.82B |
Revenue Growth % | 22.68% | 89.63% | 53.04% | 4.93% | 1.43% | -31.67% | -40.76% | -46.61% | 36.12% |
Cost of Goods Sold | 1.52B | 2.81B | 4.33B | 4.82B | 4.88B | 3.4B | 1.84B | 820.57M | 1.1B |
COGS % of Revenue | 75.86% | 74.23% | 74.75% | 79.29% | 79.11% | 80.61% | 73.83% | 61.54% | 60.8% |
Gross Profit | 482.26M▲ 0% | 976.09M▲ 102.4% | 1.46B▲ 50.0% | 1.26B▼ 13.9% | 1.29B▲ 2.3% | 817.22M▼ 36.6% | 653.7M▼ 20.0% | 512.88M▼ 21.5% | 711.63M▲ 38.8% |
Gross Margin % | 24.14% | 25.77% | 25.25% | 20.71% | 20.89% | 19.39% | 26.17% | 38.46% | 39.2% |
Gross Profit Growth % | 66.95% | 102.4% | 49.96% | -13.93% | 2.29% | -36.59% | -20.01% | -21.54% | 38.75% |
Operating Expenses | 304.87M | 596.1M | 844.74M | 1.1B | 1.2B | 1.23B | 869.22M | 857.92M | 916.56M |
OpEx % of Revenue | 15.26% | 15.74% | 14.57% | 18.01% | 19.39% | 29.29% | 34.8% | 64.34% | 50.5% |
Selling, General & Admin | 154.91M | 322.61M | 415.08M | 586.59M | 687.6M | 708.46M | 504.69M | 520.85M | 582.64M |
SG&A % of Revenue | 7.76% | 8.52% | 7.16% | 9.64% | 11.15% | 16.81% | 20.21% | 39.06% | 32.1% |
Research & Development | 149.96M | 273.49M | 429.66M | 508.64M | 508.41M | 526.2M | 364.53M | 337.07M | 317.73M |
R&D % of Revenue | 7.51% | 7.22% | 7.41% | 8.36% | 8.24% | 12.48% | 14.6% | 25.28% | 17.5% |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.2M |
Operating Income | 177.39M▲ 0% | 379.99M▲ 114.2% | 619.04M▲ 62.9% | 164.69M▼ 73.4% | 92.73M▼ 43.7% | -417.45M▼ 550.2% | -215.52M▲ 48.4% | -345.04M▼ 60.1% | -204.93M▲ 40.6% |
Operating Margin % | 8.88% | 10.03% | 10.68% | 2.71% | 1.5% | -9.9% | -8.63% | -25.88% | -11.29% |
Operating Income Growth % | 1167.19% | 114.21% | 62.91% | -73.4% | -43.7% | -550.2% | 48.37% | -60.1% | 40.61% |
EBITDA | 181.02M | 386.45M | 636.21M | 190.33M | 143.94M | -357.8M | -161.09M | -308.4M | -204.93M |
EBITDA Margin % | 9.06% | 10.2% | 10.98% | 3.13% | 2.33% | -8.49% | -6.45% | -23.13% | -11.29% |
EBITDA Growth % | 996.52% | 113.49% | 64.63% | -70.08% | -24.38% | -348.58% | 54.98% | -91.44% | 33.55% |
D&A (Non-Cash Add-back) | 3.62M | 6.46M | 17.17M | 25.65M | 51.21M | 59.65M | 54.43M | 36.64M | 0 |
EBIT | 187.07M | 401.69M | 650.61M | 251.11M | 149.59M | -321.07M | -197.31M | -382.3M | -204.93M |
Net Interest Income | 2.93M | 12.05M | 33.39M | 43.6M | -27.83M | -45.45M | -25.93M | -13.73M | -29.24M |
Interest Income | 2.93M | 12.05M | 33.39M | 43.6M | 16.47M | 12.55M | 21.86M | 26.81M | 10.7M |
Interest Expense | 0 | 0 | 0 | 0 | 44.3M | 58M | 47.79M | 40.54M | 39.94M |
Other Income/Expense | 12.42M | 23.51M | 30.46M | 81.93M | 53.06M | 56.34M | -21.7M | -108.55M | -58.2M |
Pretax Income | 189.81M▲ 0% | 403.5M▲ 112.6% | 649.5M▲ 61.0% | 246.62M▼ 62.0% | 145.78M▼ 40.9% | -361.11M▼ 347.7% | -237.22M▲ 34.3% | -453.59M▼ 91.2% | -263.13M▲ 42.0% |
Pretax Margin % | 9.5% | 10.65% | 11.2% | 4.05% | 2.36% | -8.57% | -9.5% | -34.02% | -14.5% |
Income Tax | 26.92M | 54.07M | 77.68M | 29.45M | 10.61M | -67.03M | -17.2M | 99.99M | 17.79M |
Effective Tax Rate % | 14.18% | 13.4% | 11.96% | 11.94% | 7.28% | 18.56% | 7.25% | -22.04% | -6.76% |
Net Income | 163.46M▲ 0% | 353.31M▲ 116.1% | 573.64M▲ 62.4% | 216.27M▼ 62.3% | 136.02M▼ 37.1% | -293.37M▼ 315.7% | -220.49M▲ 24.8% | -554.13M▼ 151.3% | -280.92M▲ 49.3% |
Net Margin % | 8.18% | 9.33% | 9.9% | 3.56% | 2.2% | -6.96% | -8.83% | -41.56% | -15.48% |
Net Income Growth % | 552.61% | 116.14% | 62.36% | -62.3% | -37.11% | -315.68% | 24.84% | -151.32% | 49.3% |
Net Income (Continuing) | 162.89M | 349.44M | 571.82M | 217.17M | 135.18M | -294.08M | -220.02M | -553.58M | -280.92M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 2.42M | -1.34M | -3.13M | 0 | 13.08M | 12.22M | 13.25M | 8.31M | 0 |
EPS (Diluted) | 0.65▲ 0% | 8.12▲ 1149.2% | 35.84▲ 341.4% | 2.16▼ 94.0% | 1.31▼ 39.4% | -2.71▼ 306.9% | -1.96▲ 27.7% | -34.16▼ 1642.9% | -283.04▼ 728.6% |
EPS Growth % | 118.47% | 1149.23% | 341.38% | -93.97% | -39.35% | -306.87% | 27.68% | -1642.86% | -728.57% |
EPS (Basic) | 0.68 | 8.57 | 37.61 | 2.25 | 1.38 | -2.71 | -1.96 | -34.16 | -283.04 |
Diluted Shares Outstanding | 14.86M | 14.06M | 16.15M | 16.27M | 16.52M | 15.39M | 15.2M | 16.18M | 993.87K |
Basic Shares Outstanding | 14.86M | 13.98M | 15.4M | 15.53M | 15.76M | 15.39M | 15.2M | 16.18M | 993.87K |
Dividend Payout Ratio | - | - | 0.79% | - | - | - | - | - | - |
ZEPP Balance Sheet
Zepp Health Corporation (ZEPP) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.3B | 2.86B | 4.35B | 4.82B | 3.93B | 2.92B | 2.24B | 1.84B | 2.05B |
Cash & Short-Term Investments | 389.72M | 1.6B | 1.8B | 2.29B | 1.53B | 993.2M | 1.03B | 815.51M | 789.7M |
Cash Only | 375.84M | 1.45B | 1.78B | 2.27B | 1.51B | 959.38M | 995.09M | 808.23M | 789.7M |
Short-Term Investments | 13.88M | 147.65M | 17M | 23.38M | 24.32M | 33.82M | 36.5M | 7.28M | 0 |
Accounts Receivable | 648.51M | 758.51M | 1.65B | 1.28B | 1.09B | 857.83M | 580.63M | 577.66M | 514.47M |
Days Sales Outstanding | 118.51 | 73.1 | 103.66 | 76.65 | 64.29 | 74.27 | 84.86 | 158.12 | 103.45 |
Inventory | 257.85M | 493.66M | 886.35M | 1.22B | 1.26B | 1.01B | 601.38M | 414.51M | 508.76M |
Days Inventory Outstanding | 62.12 | 64.09 | 74.67 | 92.02 | 93.91 | 108.37 | 119.05 | 184.38 | 168.28 |
Other Current Assets | 8 | 4.48M | 1.77M | 4.41M | 815.05K | 3.17M | 1.63M | 1.7M | 239.59M |
Total Non-Current Assets | 185.57M | 401.58M | 773.92M | 1.07B | 2.15B | 2.28B | 2.26B | 2.02B | 1.9B |
Property, Plant & Equipment | 29.09M | 40.1M | 171.18M | 275.18M | 242.02M | 163.79M | 111.56M | 75.59M | 53.28M |
Fixed Asset Turnover | 68.66x | 94.46x | 33.86x | 22.10x | 25.49x | 25.74x | 22.39x | 17.64x | 34.07x |
Goodwill | 6M | 5.94M | 5.87M | 62.38M | 60.98M | 65.13M | 67.87M | 69.93M | 67M |
Intangible Assets | 5.4M | 63.81M | 84.84M | 144.89M | 135.42M | 121.53M | 69.91M | 51.76M | 95.18M |
Long-Term Investments | 86.24M | 209.24M | 401.76M | 443.01M | 1.55B | 1.67B | 1.71B | 1.66B | 1.55B |
Other Non-Current Assets | 16.46M | 7.36M | 8.73M | 28.1M | 19.57M | 49.67M | 68.7M | 33.63M | 26M |
Total Assets | 1.48B▲ 0% | 3.26B▲ 120.1% | 5.12B▲ 56.9% | 5.89B▲ 15.1% | 6.08B▲ 3.2% | 5.19B▼ 14.6% | 4.5B▼ 13.3% | 3.86B▼ 14.3% | 3.95B▲ 2.4% |
Asset Turnover | 1.35x | 1.16x | 1.13x | 1.03x | 1.01x | 0.81x | 0.55x | 0.35x | 0.46x |
Asset Growth % | 52.4% | 120.07% | 56.89% | 15.07% | 3.18% | -14.58% | -13.29% | -14.3% | 2.37% |
Total Current Liabilities | 887.52M | 1.39B | 2.46B | 2.78B | 2.15B | 1.64B | 1.1B | 1.43B | 2.01B |
Accounts Payable | 716.07M | 1.07B | 1.98B | 1.95B | 1.32B | 450.04M | 264.14M | 372.8M | 564.78M |
Days Payables Outstanding | 172.51 | 138.34 | 166.68 | 147.37 | 98.4 | 48.34 | 52.29 | 165.83 | 186.81 |
Short-Term Debt | 35.66M | 38.99M | 34.61M | 551.58M | 550.43M | 996.26M | 513.98M | 765.56M | 1.17B |
Deferred Revenue (Current) | 28.89M | 47.87M | 103.26M | 94.08M | 92.1M | 62.39M | 55.51M | 37.54M | 531.44K |
Other Current Liabilities | 54.49M | 99.02M | 152.73M | 124.49M | 146.82M | 107.87M | 244.39M | 232.37M | 266.99M |
Current Ratio | 1.46x | 2.06x | 1.77x | 1.73x | 1.83x | 1.77x | 2.04x | 1.29x | 1.02x |
Quick Ratio | 1.17x | 1.70x | 1.41x | 1.29x | 1.24x | 1.16x | 1.49x | 1.00x | 0.77x |
Cash Conversion Cycle | 8.12 | -1.15 | 11.65 | 21.29 | 59.8 | 134.31 | 151.62 | 176.67 | 84.92 |
Total Non-Current Liabilities | 10.61M | 61.29M | 80.88M | 382.94M | 998.75M | 900.94M | 904.32M | 587.54M | 443.75M |
Long-Term Debt | 3.11M | 0 | 0 | 59.87M | 726M | 674.4M | 850.23M | 549.17M | 415.89M |
Capital Lease Obligations | 0 | 0 | 75.54M | 115.99M | 71.03M | 31.24M | 22.65M | 14.65M | 7.71M |
Deferred Tax Liabilities | 2.5M | 4.97M | 5.34M | 22.32M | 26.88M | 35.04M | 29.53M | 22.75M | 18.69M |
Other Non-Current Liabilities | 5M | 56.33M | 0 | 184.76M | 174.85M | 160.27M | 1.91M | 970.73K | 1.46M |
Total Liabilities | 898.13M | 1.45B | 2.54B | 3.17B | 3.15B | 2.55B | 2B | 2.01B | 2.45B |
Total Debt | 38.77M | 38.99M | 110.15M | 727.44M | 1.35B | 1.7B | 1.39B | 1.33B | 1.59B |
Net Debt | -337.07M | -1.41B | -1.67B | -1.54B | -160.3M | 742.51M | 391.76M | 521.15M | 804.83M |
Debt / Equity | 0.07x | 0.02x | 0.04x | 0.27x | 0.46x | 0.64x | 0.55x | 0.72x | 1.06x |
Debt / EBITDA | 0.21x | 0.10x | 0.17x | 3.82x | 9.36x | - | - | - | - |
Net Debt / EBITDA | -1.86x | -3.66x | -2.63x | -8.11x | -1.11x | - | - | - | - |
Interest Coverage | - | - | - | - | 3.38x | -5.54x | -4.13x | -9.43x | -5.13x |
Total Equity | 584.55M▲ 0% | 1.81B▲ 210.0% | 2.47B▲ 36.4% | 2.72B▲ 10.3% | 2.93B▲ 7.6% | 2.65B▼ 9.7% | 2.5B▼ 5.6% | 1.84B▼ 26.2% | 1.5B▼ 18.7% |
Equity Growth % | 72.68% | 209.99% | 36.36% | 10.26% | 7.55% | -9.68% | -5.57% | -26.18% | -18.67% |
Book Value per Share | 39.34 | 128.84 | 152.99 | 167.42 | 177.33 | 171.93 | 164.45 | 114.01 | 1509.40 |
Total Shareholders' Equity | 582.13M | 1.81B | 2.47B | 2.72B | 2.92B | 2.63B | 2.49B | 1.84B | 1.5B |
Common Stock | 56.66K | 151.2K | 153.34K | 156.65K | 158.81K | 159.67K | 184.19K | 189.76K | 181.81K |
Retained Earnings | 132.73M | 340.51M | 900.87M | 1.13B | 1.27B | 929.32M | 739.23M | 208.88M | -80.07M |
Treasury Stock | 0 | 0 | 0 | 0 | -21.77M | -66.2M | -91.2M | -109.43M | -112.95M |
Accumulated OCI | 22.36M | 97.27M | 109.89M | 44.53M | 29.24M | 104.28M | -99.23M | -293.25M | -278.87M |
Minority Interest | 2.42M | -1.34M | -3.13M | 0 | 13.08M | 12.22M | 13.25M | 8.31M | 0 |
ZEPP Cash Flow Statement
Zepp Health Corporation (ZEPP) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 229.83M | 720.98M | 443.55M | 150.78M | -331.77M | -117.11M | 42.6M | -24.39M | -179.65M |
Operating CF Margin % | 11.51% | 19.04% | 7.65% | 2.48% | -5.38% | -2.78% | 1.71% | -1.83% | -9.9% |
Operating CF Growth % | 1404.48% | 213.71% | -38.48% | -66.01% | -320.03% | 64.7% | 136.38% | -157.26% | -636.53% |
Net Income | 163.46M | 353.31M | 573.64M | 216.27M | 136.02M | -43.35M | -31.09M | -75.81M | -280.18M |
Depreciation & Amortization | 3.62M | 6.46M | 17.17M | 25.65M | 51.21M | 8.71M | 7.69M | 5.02M | 31.71M |
Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 7.27M | 8.79M | 4.78M | 17.43M |
Deferred Taxes | -18.49M | -34.18M | -27.72M | -9.87M | -18.45M | -9.92M | -2.88M | 13.45M | 15.65M |
Other Non-Cash Items | 58.16M | 139.78M | 112.78M | 115.18M | 119.98M | 2.44M | 12.21M | 20.51M | 145.71M |
Working Capital Changes | 23.06M | 255.61M | -232.31M | -196.44M | -620.52M | -82.26M | 47.88M | 7.66M | -109.97M |
Change in Receivables | -119.82M | -21.09M | -898.56M | 427.55M | 300.79M | 3.13M | 43.8M | 404K | -80.68M |
Change in Inventory | -56.16M | -244.05M | -431.81M | -388.27M | -82.05M | 27.92M | 51.91M | 5.55M | -154.48M |
Change in Payables | 177.06M | 370.22M | 933.32M | -9.23M | -664.51M | -135.34M | -27.82M | 14.81M | 197.86M |
Cash from Investing | -37.9M | -337.51M | -112.4M | -195.59M | -1.06B | -6.24M | 7.73M | -1.58M | 10.35M |
Capital Expenditures | -21M | -71.85M | -46M | -80.15M | -52.39M | -1.21M | -1.6M | -1.4M | -3.61M |
CapEx % of Revenue | 1.05% | 1.9% | 0.79% | 1.32% | 0.85% | 0.03% | 0.06% | 0.11% | 0.2% |
Acquisitions | 2.42M | 67.53K | 142.61K | -32.54M | 35.99M | 60K | 427K | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -14.48M | -108.68M | 103.46M | -445.28K | 0 | -2.57M | 3.25M | 1.66M | 2.29M |
Cash from Financing | 22.1M | 678.33M | 8.83M | 531.78M | 646.39M | 42.37M | -41.68M | 477K | 173.66M |
Debt Issued (Net) | 22.01M | 490.41K | -36.65M | 531.78M | 654.58M | 16.55M | -46.98M | -1.65M | -51.29M |
Equity Issued (Net) | 86.76K | 677.84M | 50.01M | 0 | -8.19M | -8.16M | -2.52M | -2.28M | -8.66M |
Dividends Paid | 0 | 0 | -4.53M | 0 | 0 | -6.3M | 0 | 0 | 0 |
Share Repurchases | 0 | -8.48M | 0 | 0 | -13.58M | -8.16M | -2.52M | -2.28M | -8.66M |
Other Financing | 0 | 0 | 0 | 0 | 0 | 40.28M | 7.82M | 4.4M | 233.61M |
Net Change in Cash | 228.45M▲ 0% | 1.06B▲ 364.7% | 327.49M▼ 69.2% | 580.78M▲ 77.3% | -707.46M▼ 221.8% | -95.76M▲ 86.5% | -652K▲ 99.3% | -29.73M▼ 4460.4% | 15.37M▲ 151.7% |
Free Cash Flow | 208.91M▲ 0% | 703.17M▲ 236.6% | 409.37M▼ 41.8% | 71.79M▼ 82.5% | -377.22M▼ 625.5% | -118.59M▲ 68.6% | 40.92M▲ 134.5% | -25.88M▼ 163.2% | -185.14M▼ 615.3% |
FCF Margin % | 10.46% | 18.57% | 7.06% | 1.18% | -6.11% | -2.81% | 1.64% | -1.94% | -10.2% |
FCF Growth % | 4512.47% | 236.59% | -41.78% | -82.46% | -625.48% | 68.56% | 134.51% | -163.25% | -615.31% |
FCF per Share | 14.06 | 50.00 | 25.35 | 4.41 | -22.83 | -7.70 | 2.69 | -1.60 | -186.28 |
FCF Conversion (FCF/Net Income) | 1.41x | 2.04x | 0.77x | 0.70x | -2.44x | 0.40x | -0.19x | 0.04x | 0.64x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 8.3M | 6.26M | 89K | 1.24M |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 512K | 0 | 62K | 0 |
ZEPP Key Ratios
Zepp Health Corporation (ZEPP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 8.5% | 35.42% | 29.48% | 26.79% | 8.33% | 4.81% | -10.52% | -8.57% | -25.52% | -16.8% |
Return on Invested Capital (ROIC) | 9.33% | 60.04% | 88.41% | 77.8% | 12.49% | 3.52% | -10.17% | -5.15% | -9.85% | -6.58% |
Gross Margin | 17.74% | 24.14% | 25.77% | 25.25% | 20.71% | 20.89% | 19.39% | 26.17% | 38.46% | 39.2% |
Net Margin | 1.54% | 8.18% | 9.33% | 9.9% | 3.56% | 2.2% | -6.96% | -8.83% | -41.56% | -15.48% |
Debt / Equity | 0.04x | 0.07x | 0.02x | 0.04x | 0.27x | 0.46x | 0.64x | 0.55x | 0.72x | 1.06x |
Interest Coverage | - | - | - | - | - | 3.38x | -5.54x | -4.13x | -9.43x | -5.13x |
FCF Conversion | 0.61x | 1.41x | 2.04x | 0.77x | 0.70x | -2.44x | 0.40x | -0.19x | 0.04x | 0.64x |
Revenue Growth | 75.94% | 22.68% | 89.63% | 53.04% | 4.93% | 1.43% | -31.67% | -40.76% | -46.61% | 36.12% |
Related:ZEPP Dividend History·ZEPP Revenue History·ZEPP Price History·ZEPP P/E History·ZEPP Financial Ratios·ZEPP Institutional Holders
ZEPP Frequently Asked Questions
Zepp Health Corporation (ZEPP) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Zepp Health Corporation (ZEPP) reported $1.84B in revenue for fiscal year 2025. This represents a 99% increase from $925.4M in 2015.
Zepp Health Corporation (ZEPP) grew revenue by 36.1% over the past year. This is strong growth.
Zepp Health Corporation (ZEPP) reported a net loss of $287.6M for fiscal year 2025.
Dividend & Returns
Zepp Health Corporation (ZEPP) has a return on equity (ROE) of -16.8%. Negative ROE indicates the company is unprofitable.
Zepp Health Corporation (ZEPP) had negative free cash flow of $185.1M in fiscal year 2025, likely due to heavy capital investments.